SEC Form 4 · accession 0001104659-19-010800
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Padmanabh P. Bhatt
Officer — Sr. VP of IP, CSO
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $36.75 | Feb 22, 2019 | A | 35,000 | A | — | Feb 22, 2029 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on February 22, 2020.